Connect with us

Technology

High-performance Computing for Life Sciences Market Expected to Grow at a CAGR of 11.6% from 2024-2031 | Revealed by InsightAce Analytic

Published

2 years ago

on

JERSEY CITY, N.J., May 28, 2024 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global High-performance Computing for Life Sciences Market– (By Component Type (Hardware, Software, and Services), By Application (Drug Discovery and Development, Genomic Analysis, Proteomics, Bioinformatics, and Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Hospitals and Clinics, and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global High-performance Computing for Life Sciences Market is expected to grow with a CAGR of 11.6% during the forecast period of 2024-2031.

Get Free PDF Report Brochure: https://www.insightaceanalytic.com/report/high-performance-computing-for-life-sciences-market/2497

The high-performance computing (HPC) sector has emerged as a vital component in advancing life sciences research and applications, offering unprecedented computational power and capabilities to tackle complex biological and medical challenges.  Key drivers of market growth include the exponential growth of biological data, fueled by advancements in genomics, proteomics, and imaging technologies, as well as the increasing demand for computational resources to model biological processes and simulate drug interactions.

Moreover, collaborations between technology companies, research institutions, and pharmaceutical companies are driving innovation in HPC solutions tailored to the specific needs of the life sciences industry. However, challenges such as data integration, privacy concerns, and the complexity of biological systems pose significant hurdles to market expansion. Nonetheless, the high-performance computing for life sciences market is poised for continued growth as advancements in computing power, data analytics, and artificial intelligence continue to revolutionize biomedical research and healthcare delivery, ultimately leading to improved patient outcomes and the development of novel therapeutic interventions.

List of Prominent Players in the High-performance Computing for Life Sciences Market:

HP EnterpriseAWS Inc.Advanced Clustering TechnologiesRescaleIBM Corp.Alibaba CloudDell, NVIDIA Corp.BIO-HPCMicrosoft AzureNVIDIA Corp.CGGNimbix

High-performance Computing for Life Sciences Market Report Scope:

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 11.6% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Component Type, By Application, By End-user and By Region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Order Full 180 Pages Report @ https://www.insightaceanalytic.com/buy-report/2497 

Market Dynamics:

Drivers:

 One of the primary drivers is the exponential growth in biological and biomedical data generated by various sources such as genomic sequencing, medical imaging, and electronic health records. This explosion of data necessitates advanced computational capabilities to process, analyze, and derive meaningful insights, driving demand for HPC solutions tailored to life sciences applications. Moreover, the increasing complexity of biological research questions and the quest for precision medicine are driving the need for sophisticated computational models and simulations. HPC enables researchers to perform complex simulations, molecular modeling, and drug discovery studies with greater accuracy and speed, accelerating the pace of discovery and development in life sciences.

Additionally, the convergence of multi-omics data, including genomics, proteomics, and metabolomics, is driving demand for integrated computational platforms capable of analyzing and integrating diverse datasets. HPC systems equipped with advanced analytics and machine learning algorithms enable researchers to uncover hidden patterns, biomarkers, and therapeutic targets from large-scale omics datasets, paving the way for personalized medicine and targeted interventions.

Challenges:

There’s the challenge of cost associated with implementing and maintaining HPC infrastructure. High-performance computing systems require a substantial initial investment in hardware, software, and skilled personnel, making them financially prohibitive for some organizations, particularly smaller research institutions, and laboratories with limited budgets.

Moreover, there’s the issue of data management and storage. Life sciences research generates enormous volumes of data, including genomic sequences, imaging data, and simulations, which can quickly overwhelm traditional storage systems. Ensuring efficient data management, storage, and accessibility while maintaining data integrity and security poses a significant challenge for HPC systems in the life sciences. Furthermore, software and algorithm development are complex.

Designing and optimizing algorithms for HPC systems to analyze large-scale biological datasets efficiently requires specialized expertise in both computational biology and high-performance computing. Additionally, ensuring the accuracy and reproducibility of results generated by HPC systems is essential for gaining insights into complex biological processes and advancing scientific knowledge.

Regional Trends:

In North America, the high-performance computing (hpc) for life sciences market is characterized by advanced technological infrastructure, a strong presence of leading research institutions and pharmaceutical companies, and significant government investments in life sciences research.

The region witnesses extensive adoption of HPC systems for tasks such as genomic sequencing, drug discovery, and biomedical simulations. Moreover, favorable regulatory frameworks and robust funding opportunities further propel market growth in North America. In the Asia-Pacific (APAC) region, the HPC for Life Sciences Market is experiencing rapid expansion driven by factors such as increasing healthcare expenditure, growing investments in research and development, and rising collaborations between academic institutions and industry players. Countries like China, Japan, and India are emerging as key players in the APAC market, leveraging HPC systems to accelerate advancements in genomics, personalized medicine, and drug development. Additionally, government initiatives aimed at promoting innovation and strengthening healthcare infrastructure contribute to market growth in the APAC region.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2497 

Recent Developments:

In February 2024, Quantum Corporation finalized its acquisition of XENON Systems, a prominent provider of high-performance computing and data storage solutions. The acquisition was primarily driven by Quantum’s interest in integrating XENON Systems’ expertise into its Quantum Myriad software platform. This strategic move aims to offer comprehensive end-to-end data management solutions tailored for artificial intelligence models and multi-variant simulations across diverse industries, including life sciences.In November 2023, Quantum software innovator Classiq announced a groundbreaking industry initiative known as the Quantum Computing for Life Sciences & Healthcare Center. Developed in partnership with NVIDIA and the Tel Aviv Sourasky Medical Center, this initiative is dedicated to advancing the development and application of quantum algorithms and technologies within the realms of life sciences and healthcare. The center aims to leverage quantum computing’s transformative potential to address critical challenges in these fields.

Segmentation of High-performance Computing for Life Sciences Market-

High-performance Computing for Life Sciences Market- By Component Type

HardwareSoftwareServices

High-performance Computing for Life Sciences Market- By Application

Drug Discovery and DevelopmentGenomic AnalysisProteomicsBioinformaticsOthers

High-performance Computing for Life Sciences Market- By End User

Pharmaceutical and Biotechnology CompaniesAcademic and Research InstitutionContract Research Organizations (CROs)Hospitals and ClinicsOthers

High-performance Computing for Life Sciences Market- By Region

North America–

The USCanadaMexico

Europe–

GermanyThe UKFranceItalySpainRest of Europe

Asia-Pacific–

ChinaJapanIndiaSouth KoreaSouth East AsiaRest of Asia Pacific

Latin America–

BrazilArgentinaRest of Latin America

 Middle East & Africa–

GCC CountriesSouth AfricaRest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2497 

Why should buy this report:

To receive a comprehensive analysis of the prospects for global High-performance Computing for Life Sciences marketTo receive industry overview and future trends of global High-performance Computing for Life Sciences marketTo analyze the High-performance Computing for Life Sciences market drivers and challengesTo get information on the High-performance Computing for Life Sciences market size value (US$ Mn) forecast till 2031Major Investments, Mergers & Acquisition in global High-performance Computing for Life Sciences industry

Other Related Reports Published by InsightAce Analytic:

Life Sciences Next Gen Customer Engagement Platform Market 

AI In Life Science Analytics Market 

Life Science Tools Market 

Healthcare Middleware Market

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact Us:
InsightAce Analytic PVT. LT
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Follow us on LinkedIn: https://www.linkedin.com/company/insightace-analytic-pvt-ltd/

Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/high-performance-computing-for-life-sciences-market-expected-to-grow-at-a-cagr-of-11-6-from-2024-2031–revealed-by-insightace-analytic-302156530.html

SOURCE InsightAce Analytic Pvt. Ltd

Related Topics:
Continue Reading

Technology

3M announces collaboration with GSEO to advance Expanded Beam Optical manufacturing and development

Published

52 minutes ago

on

October 19, 2026

By

ST. PAUL, Minn., Oct. 19, 2026 /PRNewswire/ — 3M (NYSE: MMM) today announced a collaboration with Genius Electronic Optical Co., Ltd. (GSEO, Taiwan: 3406), an optical technology company, to advance technology development and manufacturing for 3M’s Expanded Beam Optical (EBO) solutions. In support of these efforts, 3M expects to make a strategic investment to acquire approximately 4.7% of GSEO’s common shares as part of the company’s private placement of newly issued shares, subject to customary closing conditions.

The collaboration brings together 3M’s EBO technology leadership, optical interconnect expertise, materials science, manufacturing scale and customer relationships with GSEO’s precision optics manufacturing capabilities and production scale. Together, the companies aim to support EBO commercialization and long-term capacity expansion to meet growing demand from hyperscale data centers and other advanced connectivity applications.

“3M is investing in capabilities and partnerships that can accelerate innovation for our customers,” said William Brown, 3M Chairman and CEO. “By selecting GSEO as a manufacturing partner and investing in the company, we are strengthening the path to scale next-generation optical connectivity solutions for high-performance data center infrastructure.”

GSEO’s existing precision optics manufacturing capabilities and technical development experience are expected to support manufacturing readiness for 3M’s EBO ferrules, co-packaged optics solutions and related optical interconnect applications. The collaboration is part of 3M’s broader EBO ecosystem strategy, which includes continued work with customers and partners across the optical interconnect market.

“GSEO is pleased to expand its relationship with 3M as we work together to advance optical interconnect solutions for next-generation data center infrastructure,” said Micro Kuo, GSEO CEO and President. “This collaboration brings together complementary technology and manufacturing strengths to support continued innovation and help meet the performance demands of high-growth connectivity markets.”

3M expects the strategic investment to close in the fourth quarter of 2026, subject to customary closing conditions.

Forward-Looking Statements
Certain statements in this release are considered “forward-looking statements” under the federal securities laws, including the Private Securities Litigation Reform Act of 1995, as amended, and are intended to enjoy the protection of those laws. Forward-looking statements may appear throughout this release and are typically identified by the words “aim,” “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “evaluate,” “expect,” “forecast,” “future,” “goal,” “guidance,” “impact,” “initial,” “intend,” “likely,” “may,” “outlook,” “plan,” “possible,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “would,” and other words that are similar to, or have the opposite meanings of, those words. Forward-looking statements speak only as of the date they are made, 3M assumes no duty to update those statements, and readers are cautioned not to place undue reliance on any of those statements. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of 3M’s Form 10-K for the year ended December 31, 2025.

About 3M
3M (NYSE: MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M.com/news.

Contacts
3M
Investor Contact:
Diane Farrow, 612-202-2449
Media Contact:
3MNews@mmm.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/3m-announces-collaboration-with-gseo-to-advance-expanded-beam-optical-manufacturing-and-development-302913170.html

SOURCE 3M Company

Continue Reading

Technology

Scott Vicknair Personal Injury Lawyers Announces Second Annual Operation Fur-Ever Home Pet Adoption Event at Lafreniere Park

Published

52 minutes ago

on

October 19, 2026

By

NEW ORLEANS, Oct. 19, 2026 /PRNewswire/ — Scott Vicknair Personal Injury Lawyers is excited to announce the return of its second annual Operation Fur-Ever Home, a free community pet adoption event taking place on Saturday, November 14, 2026, from 9:00 a.m. to 11:00 a.m. at Lafreniere Park in Metairie, Louisiana.

The free, family-friendly event will give attendees the opportunity to meet adoptable pets from local animal shelters, learn about responsible pet ownership, and potentially welcome a new furry companion into their homes. Those who preregister for the event will also be entered for a chance to win a Soundcore speaker and a free pet adoption.

“Last year’s event was everything we hoped it would be, and we are incredibly excited to bring Operation Fur-Ever Home back for a second year,” said David Vicknair, founding partner of Scott Vicknair Personal Injury Lawyers. “There is something special about watching a family meet a pet that could become part of their lives for years to come. We wanted to create another opportunity to make those connections while supporting the organizations that work tirelessly to care for animals in our community.”

Building on the success of the first event, this year’s event continues the firm’s commitment to supporting local animal shelters and creating meaningful opportunities for families throughout Southeast Louisiana.

“Giving back to our community has always been an important part of who we are as a firm,” said Vicknair. “Whether we are helping students prepare for school, recognizing deserving teachers, or supporting local animal shelters, our goal is to make a positive difference in the communities we serve.”

Operation Fur-Ever Home is free and open to the public. Families, animal lovers, and anyone interested in adopting a pet are encouraged to attend and preregister.

About Scott Vicknair Personal Injury Lawyers

Scott Vicknair Personal Injury Lawyers is a New Orleans-based personal injury firm committed to providing exceptional legal representation while also investing in the communities it serves. Their experienced team of dedicated attorneys specializes in car accidents, personal injury, and wrongful death cases in New Orleans. With diverse personal and professional backgrounds, they craft legal strategies tailored to each client’s specific case and needs.

View original content:https://www.prnewswire.com/news-releases/scott-vicknair-personal-injury-lawyers-announces-second-annual-operation-fur-ever-home-pet-adoption-event-at-lafreniere-park-302913183.html

SOURCE Scott Vicknair Personal Injury Lawyers

Continue Reading

Technology

Can we produce low-cost omega-3s without relying on fish?

Published

53 minutes ago

on

October 19, 2026

By

GOLD COAST, Australia, Oct. 19, 2026 /PRNewswire/ — Southern Cross University researchers are aiming to halve the cost of producing omega-3 supplements to make these essential nutrients more accessible to pregnant women and infants in low-income countries, backed by the University’s first-ever grant from The Gates Foundation.

The research takes a novel approach: rather than relying on fish oil, the team is going closer to the original source of omega-3. Fish don’t produce omega-3 themselves – they accumulate it from marine microorganisms lower in the food chain.

Led by Professor Dirk Erler from Southern Cross University’s Faculty of Science and Engineering, the team is investigating how these naturally omega-3-producing microorganisms can be grown more cheaply through precision fermentation, including the use of agricultural and food-processing by-products as a source of fermentation sugar.

Omega-3 is an important nutrient during pregnancy and early life, supporting brain and nervous system development in babies. But the cost of supplements remains a significant barrier to access in many low-income countries.

“The main barrier for the uptake of omega-3s as supplements in pregnant women is the cost,” Professor Erler said.

“The whole objective of our project is to reduce that cost and make omega-3 supplements more available.”

The research team at Southern Cross University, which includes biomedical scientist Dr Nedeljka Rosic, Dr Shane McIntosh, postdoctoral researcher Dr Jasmine Haskell and PhD researcher Michael Ingram, is focused on growing omega-3-producing marine microorganisms known as thraustochytrids – or ‘throstys’ for short.

“By growing those microorganisms on land through precision fermentation, we have an alternative way of producing omega-3s that is both reliable and highly targeted,” Professor Erler said.

Precision fermentation allows the researchers to grow thraustochytrids under controlled conditions to produce omega-3 oils. The team is investigating whether expensive feedstocks used in the process can be replaced with lower-cost agricultural and food-processing by-products, helping drive down the overall cost of production.

The approach could also reduce reliance on wild-caught fish as a source of omega-3 oil and create a more reliable, scalable, and local supply.

For biomedical scientist Dr Nedeljka Rosic, the production challenge is ultimately about what greater access to omega-3 could mean for women and babies.

“As a biomedical scientist, my purpose is to find ways to use science to improve people’s health,” Dr Rosic said.

“This project is important because it aims to improve the health of pregnant women and children and reduce preterm births through simple dietary improvements.”

View original content to download multimedia:https://www.prnewswire.com/news-releases/can-we-produce-low-cost-omega-3s-without-relying-on-fish-302893631.html

SOURCE Southern Cross University

Continue Reading

Trending